Xvivo Perfusion AB (0RKL.LSE) Q1 2025 Earnings

28JanConfirmed
Q1 2024
Q3 2024
Q4 2024
Q1 2025
0.4
1.21
2.03
2.85

Details

Expected EPS
1.370088863154
Actual EPS
1.14771096
Surprise EPS
-0.22
Surprise Percent
+16.23%

Description

Xvivo Perfusion AB (0RKL.LSE) has reported earnings of 1.14771096 per share for Q1 2025.

0 Comments

Share your thoughts